# FDA & the rules for what you build: where it stands

The line between a helpful tool and a regulated medical device, and the federal and state rules on AI in care. FDA's clinical decision support guidance draws the federal line. States are adding their own: California's AB 1979 and SB 503, effective January 1, 2027, set duties for clinical AI and its developers and deployers. Federally, ONC dropped its AI transparency requirements for certified EHRs in October 2026.

Notes, newest first (2):

- 2026-10-26 [ONC finalizes HTI-5, dropping 14 certification criteria and AI transparency rules](https://mddev.health201.com/entry/onc-hti-5-final-rule-certification-ai-2026/): On October 26, 2026, HHS's Office of the National Coordinator for Health IT (ONC/ASTP) released the HTI-5 final rule.
- 2026-09-30 [California enacts AB 1979 and SB 503 setting rules for clinical AI tools](https://mddev.health201.com/entry/california-ab-1979-sb-503-clinical-ai-2026/): On September 30, 2026, Governor Gavin Newsom signed AB 1979 and SB 503, both effective January 1, 2027.

From MD-dev, https://mddev.health201.com/stack/regulation/
